Engineered two-helix small proteins for molecular recognition.

Area of Science:

• Protein Engineering
• Biotechnology
• Molecular Biology

Background:

• High-affinity protein binders are crucial for targeted therapies.
• Affibody molecules are a class of small protein binders with therapeutic potential.
• Developing smaller, highly effective binders remains a key challenge.

Purpose of the Study:

• To engineer novel 2-helix small protein binders with high affinity for HER2.
• To explore strategies for reducing the size of protein binders while maintaining or improving affinity.
• To demonstrate the feasibility of rational design for creating potent 2-helix binders against tumor targets.

Main Methods:

• Utilized a high-affinity 3-helix affibody molecule as a starting point.
• Employed a combination of rational protein design and engineering strategies.
• Iteratively modified the protein structure to achieve the desired 2-helix conformation and affinity.

Main Results:

• Successfully developed 2-helix small protein binders.
• Achieved nanomolar affinities (5 nM) for HER2 binding.
• Demonstrated that reducing helix count can yield effective binders.

Conclusions:

• The "less is more" approach is effective in protein binder design.
• Rational design and engineering can yield potent 2-helix protein binders.
• This work opens avenues for developing smaller, targeted therapeutics for HER2-expressing tumors.